Vaccines against Toxoplasma gondii: new developments and perspectives.
about
DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in miceRecombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c miceImpact of environmental factors on the emergence, transmission and distribution of Toxoplasma gondiiEvaluation of Protective Immune Responses Induced by Recombinant TrxLp and ENO2 Proteins against Toxoplasma gondii Infection in BALB/c MiceProtective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticlesImmunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice.Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in miceProtective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in miceEvaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine modelCloning and Expression of Major Surface Antigen 1 Gene of Toxoplasma gondii RH Strain Using the Expression Vector pVAX1 in Chinese Hamster Ovary Cells.Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infectionPrime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseA Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Advantages and disadvantages of conditional systems for characterization of essential genes in Toxoplasma gondii.Recent advances in developing vaccines against Toxoplasma gondii: an update.Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models.Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.Calcium phosphate nanoparticles as a new generation vaccine adjuvant.Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16.Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles.SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice.Evaluation of Immune Responses Induced by GRA7 and ROP2 Genes by DNA Vaccine Cocktails Against Acute Toxoplasmosis in BALB/c Mice.Molecular Cloning, Expression and Characterization of Plasmid Encoding Rhomboid 4 (ROM4) of Tachyzoite of Toxoplasma gondii RH Strain.Moving towards improved vaccines for Toxoplasma gondii.Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice.Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice.Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis.
P2860
Q22773213-D7F4DCF5-C702-4FB1-BC8F-E4E1CD60F501Q23071101-DD5A5A23-677F-4233-8FAF-0970E1B42FD8Q26766436-9A3900D1-0620-480A-BC1E-509C3C04DFBFQ28821308-F0E3E331-933F-4547-AE1D-C4788FF8AA23Q28846409-95938611-6E1A-400B-8F64-59CC55AEDFB2Q33776827-982369A3-5D4C-4EC9-B6B6-BA6A6BBC6FA3Q33849618-9FE7DFE3-A674-4873-9A05-5179BFE78EEEQ33899385-90451339-775E-460C-A547-EEB6F4DE3797Q34196487-CF7F7F56-239A-444A-B53D-50519D4F46ECQ34494113-0B92E36C-98B0-4C7F-A6EF-E4FE3D6D4AFDQ34501283-44262944-BB76-4A7B-B5BC-BF448D6BD672Q34667736-65334FA2-0824-4BE1-B4BC-B8C67EF731D0Q35276317-D0586C18-2A24-41DB-90CD-5BB41EE2814BQ35439431-09A3A397-6EC1-401F-9F40-5B4B891FC4F1Q35641195-D0B53915-83DD-43F6-B827-A641702F5A3BQ35819992-A65E9896-D24C-4613-AA12-8FD5A5DAC8BFQ35993075-038C433D-2627-48B4-88C7-BA65058D88EFQ36010732-B7A44D5D-D995-4BDA-B04B-4C2D55C0B158Q37126611-9BE0CB42-0A46-4856-A4A4-5B12E0F63E28Q37594988-5DE18D92-E78A-4507-831C-55ED7EBBB57CQ37737615-1DAE5592-11EB-4236-826B-27188D3616EAQ38220015-F1189483-4B3F-4AB4-BC7B-427A8C166C0FQ38607376-E973725F-475D-43EB-84CE-3FEE680FCF91Q38655231-9CFF15F9-7E72-4AFF-BD6E-A1EABBA2D11AQ39378103-4545380C-85B3-4D7B-A51D-4B22F46D457CQ39437472-73ACB9B6-31AE-48F0-9773-3BC64900641AQ40065419-421BAF45-2D40-49A2-8D18-7934381492A4Q41017277-E3A61248-513D-4D33-8B12-E074DB24D765Q41071634-56814304-EEF7-4DD7-B558-CE0FF0678A8EQ41312105-C71EAF56-7570-4C5C-8D4D-D24F8275391FQ47121882-D24B99DC-8AAC-4252-A1E6-615AA12ECC76Q47256167-5777BC3A-C820-4A4D-9127-8647C1331E78Q47318857-2F7B8275-EDD0-436D-B6F8-60973D04FAC0Q47840789-1651EC46-675A-4B7E-89A5-28AF73A78C31Q48108940-E8AB1BE9-54B1-4537-B8F6-85C96BF63A15Q48109140-C9A9B372-2245-4565-BBE2-2E11584A3AC6Q48292361-73D2B259-8971-4B74-A70E-2F1474CCD2BFQ52424309-3951F65A-E4CF-4F9B-B50F-72083A46D3D1Q52668845-603C5064-E9C9-46B7-838F-1D16E5E2D5E4Q55397848-64C5F3C3-CD7B-482C-A6ED-CCF78600AD3A
P2860
Vaccines against Toxoplasma gondii: new developments and perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vaccines against Toxoplasma gondii: new developments and perspectives.
@en
type
label
Vaccines against Toxoplasma gondii: new developments and perspectives.
@en
prefLabel
Vaccines against Toxoplasma gondii: new developments and perspectives.
@en
P2860
P50
P1476
Vaccines against Toxoplasma gondii: new developments and perspectives.
@en
P2093
P2860
P304
P356
10.1586/14760584.2013.844652
P577
2013-10-04T00:00:00Z